As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.
However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results